Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
Status:
Completed
Trial end date:
2015-03-03
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to evaluate the safety and efficacy of GS-4774 in
adults with chronic hepatitis B (CHB) viral infection who have been virally suppressed with
an oral antiviral (OAV) medication.